Ontario invests US$15m in state-of-the-art newborn screening programme
This article was originally published in Clinica
Executive Summary
Ontario will invest Can$18m (US$15m) to develop what will be the most comprehensive newborn screening programme in the country. Can$5m will be spent on one-time equipment purchases, followed by Can$13m in ongoing, annual funding. The hospital chosen as the site for the state-of-the-art programme is the Children's Hospital of Eastern Ontario. Facilities and procedures available will include: three tandem mass spectrometry machines to screen for inherited metabolic disorders (IMD); screening for blood and endocrine disorders (26 tests) using additional technologies, such as automated enzyme assays, immunoassays, high-pressure liquid chromatography and/or electrophoresis.